Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Transfection Technologies Market Size Forecast: How Large Could The Market Become By 2030?
The market for transfection technologies has experienced robust expansion in recent years, with projections indicating an increase from $1.31 billion in 2025 to $1.42 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.8%. This historical growth has been driven by factors such as the advancement of molecular biology research, progress in gene expression studies, rising demands for protein production, increased financial support for genomics research, and its early adoption within academic laboratories.
The transfection technologies market is anticipated to experience robust expansion over the coming years. By 2030, it is projected to reach $1.99 billion, driven by a compound annual growth rate (CAGR) of 8.7%. This forecast period growth can be linked to the rise of cell and gene therapies, an expanding pipeline for RNA therapeutics, increased funding in life sciences research, a growing need for effective transfection reagents, and the widening scope of personalized medicine. Key trends shaping this period include a heightened demand for gene editing research instruments, progress in RNA-based therapeutic development, broader application in cell and gene therapy, expansion of academic and biomedical studies, and improvements in non-viral transfection approaches.
Download A Free Sample Report For Comprehensive Market Insights:
Transfection Technologies Market Demand Drivers: What Is Fueling Industry Growth?
The continued expansion of gene therapy is anticipated to drive the transfection technologies market forward. This medical approach works by modifying genetic material—through the introduction, correction, or replacement of defective genes—to treat or prevent illnesses. Growth in this field is fueled by breakthroughs in genetic research, improved vectors and delivery systems, and the potential to address disorders once deemed untreatable. For gene therapy to succeed, transfection technologies play a vital role by enabling the accurate, secure, and efficient transfer of genetic material into target cells. These tools enable both transient and stable genetic alterations, which are critical in the treatment of hereditary conditions and malignancies. As an illustration, in December 2024 the American Society of Gene & Cell Therapy (ASGCT)—a US-based nonprofit medical and scientific body—reported that the FDA authorized six gene therapy products in 2023, compared with five in 2022. Consequently, the upsurge in gene therapy is fueling the expansion of the transfection technologies market.
Transfection Technologies Market Segment Analysis And Revenue Opportunities
The transfection technologies market covered in this report is segmented –
1) By Product: Kits And Reagents, Equipment, Other Products
2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods
3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users
Subsegments:
1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents
2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment
3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions
Transfection Technologies Market Innovation Trends: Which Developments Are Transforming The Industry?
Leading players in the transfection technologies market are concentrating on creating cutting-edge innovations, specifically mechanoporation transfection systems, to support increasingly complex and tailored applications in both research and therapeutic fields. Through the application of mechanical forces, mechanoporation transfection systems generate temporary openings in cell membranes, facilitating the entry of genetic material. This technique is both effective and gentle, ensuring improved cell viability. A notable example is from July 2024, when STEMCELL Technologies, a biotechnology firm headquartered in Canada, introduced CellPore, a novel transfection system. This system comprises a benchtop device and the CellPore Transfection Kit 300, which includes a specialized reagent kit along with disposable delivery cartridges. By utilizing controlled, rapid deformation within microfluidic channels, CellPore effectively introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, resulting in minimal cellular disruption and high survival rates. Such attributes are essential for progressing research and the creation of groundbreaking cell and gene therapies.
Transfection Technologies Market Leading Players Shaping Industry Direction
Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.
Access The Complete Transfection Technologies Market Report:
Transfection Technologies Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model